JS BIOFUTURE INVEST ApS: Financial statements 2019
CVR: 31080983
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,625 and a net result of DKK 38,605 compared with DKK -13,469 the year before. Equity in the 2019 report amounted to DKK 51,599. The solvency ratio was 21.9%.
- Gross Profit
- DKK -5,625
- Profit/Loss
- DKK 38,605
- Equity
- DKK 51,599
- Total Assets
- DKK 235,492
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -6K | 39K | 52K | - |
| 2018 | - | -4K | -13K | 13K | - |
| 2017 | - | -8K | 3K | 26K | - |
| 2016 | - | -4K | -20K | 24K | - |
| 2015 | - | -9K | 5K | 43K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JS BIOFUTURE INVEST ApS has published its annual report for 2018. Gross profit came to DKK -4,375, and the net result was DKK -13,469.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.